Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,9.97779323347856e-50,283.47359597652974,31984.011944489852,"['RPL5', 'RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPLP0', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS17', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL36', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPS11', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPS6', 'RPL22', 'RPL13A', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL28', 'UBA52', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPL14', 'RPS3', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'RPS20', 'FAU', 'RPS21', 'RPS24', 'RPS23']",4.140784191893602e-47,0,0,77
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,3.928748433809808e-33,42.75672997522709,3190.378371493379,"['COX7B', 'NDUFA12', 'COX4I1', 'COX6A1', 'COX7C', 'ATP5IF1', 'UQCRFS1', 'COX8A', 'NDUFC2', 'NDUFC1', 'COX6B1', 'NDUFS6', 'NDUFS5', 'NDUFS3', 'SLC25A5', 'SLC25A4', 'SLC25A6', 'NDUFB9', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB5', 'NDUFB4', 'COX17', 'NDUFB3', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX5A', 'UQCRH', 'ATP5MC1', 'ATP5F1A', 'ATP5F1B', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA8', 'NDUFA7', 'ATP5PD', 'NDUFA6', 'NDUFA5', 'ATP5PB', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'COX6C', 'ATP5F1D', 'ATP5F1E', 'UQCRQ', 'NDUFAB1', 'ATP5PO']",8.152153000155352e-31,0,0,59
3,Nonalcoholic fatty liver disease WP4396,9.21977380114496e-20,10.549662487945998,462.395413535065,"['NDUFA13', 'COX7B', 'NDUFA11', 'NDUFA12', 'COX4I1', 'COX6A1', 'COX7C', 'UQCRFS1', 'COX8A', 'NDUFC2', 'NDUFC1', 'COX6B1', 'NDUFS6', 'DDIT3', 'NDUFS5', 'NDUFS3', 'NDUFB9', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB11', 'NDUFB5', 'NDUFB4', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX5A', 'UQCRH', 'SOCS3', 'CYC1', 'NDUFA8', 'XBP1', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'COX6C', 'UQCRQ', 'NDUFAB1', 'CYCS', 'BAX']",1.2754020424917196e-17,0,0,50
4,Oxidative phosphorylation WP623,4.1193126739763326e-19,31.096153846153847,1316.4068659266584,"['NDUFB9', 'NDUFB8', 'NDUFB7', 'NDUFA11', 'NDUFB10', 'NDUFB5', 'NDUFB4', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'ATP5MC1', 'ATP5F1A', 'ATP5F1B', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA8', 'NDUFA7', 'NDUFA6', 'ATP5PD', 'NDUFA5', 'ATP5PB', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFC2', 'NDUFC1', 'ATP5F1D', 'ATP5F1E', 'NDUFS6', 'NDUFS5', 'NDUFAB1', 'NDUFS3', 'ATP5PO']",4.273786899250445e-17,0,0,35
5,Mitochondrial complex I assembly model OXPHOS system WP4324,2.8767919910538e-14,23.83407079646018,743.134780317375,"['NDUFB9', 'NDUFA13', 'NDUFB8', 'NDUFB7', 'NDUFB10', 'NDUFA12', 'NDUFB11', 'NDUFB5', 'NDUFB4', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'NDUFA8', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'NDUFC2', 'NDUFC1', 'NDUFS6', 'NDUFS5', 'NDUFAF4', 'NDUFAB1', 'NDUFS3', 'NDUFAF3']",2.387737352574654e-12,0,0,27
6,Mitochondrial CIV Assembly WP4922,2.2215429925751938e-10,31.564696485623003,701.6089921839164,"['COX8A', 'COA3', 'COX7B', 'PET100', 'NDUFA4', 'TACO1', 'COX4I1', 'COX17', 'COX7A2', 'COX6A1', 'HIGD1A', 'COX5B', 'COX6C', 'COX5A', 'COX7C', 'PET117', 'COX6B1', 'COX14']",1.536567236531176e-08,0,0,18
7,mRNA Processing WP411,2.7581752657366634e-05,5.822045152722444,61.12190347347367,"['SF3B5', 'SF3A1', 'NCBP2', 'SNU13', 'LSM2', 'LSM7', 'SNRPD1', 'SNRPG', 'SRSF3', 'SNRPE', 'SNRPB2', 'DNAJC8', 'HNRNPA1', 'SNRPB', 'SRSF9']",0.001635203907543879,0,0,15
8,Mitochondrial complex III assembly WP4921,4.537401256429234e-05,27.84152139461173,278.4311122144766,"['UQCRB', 'UQCC3', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'CYC1', 'UQCRH']",0.0023537769017726654,0,0,8
9,DNA Repair Pathways Full Network WP4946,0.0001246310221822307,4.298859035701141,38.64740049260207,"['FEN1', 'RFC3', 'CENPX', 'MGMT', 'RPA2', 'RAD23A', 'GTF2H5', 'POLE4', 'POLD4', 'NEIL2', 'NTHL1', 'TDG', 'APEX1', 'POLD2', 'POLE3', 'POLE']",0.0052727377217906815,0,0,16
10,Base Excision Repair WP4752,0.00012705392100700438,8.708333333333334,78.1215786763142,"['POLE4', 'POLD4', 'FEN1', 'NEIL2', 'NTHL1', 'TDG', 'APEX1', 'POLD2', 'POLE3', 'POLE']",0.0052727377217906815,0,0,10
11,Pyrimidine metabolism WP4022,0.00023426864955099496,3.7115422984836393,31.0249380548078,"['NME2', 'NME1', 'POLE4', 'POLD4', 'ZNRD1', 'POLD2', 'POLE3', 'POLR2E', 'POLR2G', 'POLR3H', 'POLR2I', 'POLE', 'DCTPP1', 'POLR2J', 'POLR3K', 'POLR2K', 'POLR2L']",0.008838317233060264,0,0,17
12,Nucleotide Excision Repair WP4753,0.00041106723062124745,7.831284694686756,61.05859853530866,"['POLE4', 'POLD4', 'RFC3', 'POLD2', 'POLE3', 'RPA2', 'RAD23A', 'POLE', 'GTF2H5']",0.014216075058984808,0,0,9
13,Cellular Proteostasis WP4918,0.0005637903282602486,inf,inf,"['VBP1', 'PFDN2', 'PFDN4', 'PFDN5', 'PFDN6']",0.017997922017538706,0,0,5
14,Computational Model of Aerobic Glycolysis WP4629,0.0006570062605762723,12.16825019794141,89.16671078836902,"['LDHA', 'TPI1', 'PKM', 'PGK1', 'ALDOA', 'GAPDH', 'PFKM']",0.019475542724225213,0,0,7
15,Eukaryotic Transcription Initiation WP405,0.0009222940437862237,6.263600317208565,43.77408821969177,"['GTF2A2', 'TAF13', 'POLR2E', 'POLR2G', 'POLR3H', 'POLR2I', 'POLR2J', 'POLR3K', 'POLR2K']",0.025516801878085523,0,0,9
16,VEGFA-VEGFR2 Signaling Pathway WP3888,0.0013727655272271972,1.7968228031953521,11.84272961830328,"['YWHAE', 'RPL5', 'SET', 'NOTCH4', 'CLTC', 'CCDC124', 'ARPC5L', 'CRIP2', 'FOXO4', 'TXN', 'RPL10A', 'RPL7', 'ICAM1', 'ACTG1', 'LDHA', 'RPL18A', 'ADAMTS1', 'TMSB4X', 'CFL1', 'RACK1', 'AP2S1', 'PGK1', 'RPLP2', 'DNAJB9', 'ELOC', 'ATP6V1E1', 'RPS11', 'CCT7', 'TMSB10', 'HRAS', 'SLC25A25', 'SDF2L1', 'SSR4', 'RPS6', 'SARS', 'RPL13A', 'DNAJA1', 'PTPN9', 'CYCS', 'RPL27', 'RPL26', 'ATP6V0D1', 'ALDOA', 'GAPDH', 'PTMA', 'ARF6']",0.035606105862455426,0,0,46
17,DNA Mismatch Repair WP531,0.0017653597214651441,8.110319345473739,51.41456495641966,"['POLE4', 'POLD4', 'RFC3', 'POLD2', 'POLE3', 'RPA2', 'POLE']",0.0430955461416491,0,0,7
18,Cholesterol Biosynthesis Pathway WP197,0.0023096016648719215,10.421677215189874,63.266669612413345,"['IDI1', 'NSDHL', 'HMGCS1', 'CYP51A1', 'PMVK', 'MSMO1']",0.05044656268009723,0,0,6
19,Cori Cycle WP1946,0.0023096016648719215,10.421677215189874,63.266669612413345,"['LDHA', 'TPI1', 'PGAM1', 'PGK1', 'ALDOA', 'GAPDH']",0.05044656268009723,0,0,6
20,7q11.23 copy number variation syndrome WP4932,0.0026760937358670505,2.789792663476874,16.525049797488954,"['ATP5PB', 'CLTC', 'ATP5MC2', 'HMGA1', 'ATP5MC3', 'ATP5F1D', 'ATP5F1E', 'ATP5MC1', 'ATP5F1A', 'ATP5F1B', 'DNAJC30', 'CFL1', 'EIF4H', 'ATP5PO', 'GAPDH', 'VAMP2']",0.0555289450192413,0,0,16
21,Translation Factors WP107,0.0038424805519720697,3.8659611992945324,21.501073402717342,"['EEF1B2', 'EEF1G', 'EIF2B2', 'EIF5', 'EIF6', 'EIF3I', 'EIF4H', 'EIF3G', 'EIF4B', 'EIF1']",0.07593473471754329,0,0,10
22,Proteasome Degradation WP183,0.006046177831500777,2.829206443914081,14.45251723948418,"['H2AFZ', 'HLA-B', 'PSMB10', 'PSMA7', 'PSMD8', 'PSMB6', 'PSMC5', 'PSMD7', 'PSMB5', 'PSMC3', 'PSMA2', 'PSME3', 'PSME1']",0.1140529000033101,0,0,13
23,Selenium Micronutrient Network WP15,0.010042417536406825,2.3746830858384644,10.925768230440337,"['SERPINA3', 'GPX4', 'HBA1', 'TXN', 'SELENOK', 'ICAM1', 'SELENOH', 'SOD1', 'SELENOM', 'PRDX5', 'SELENOS', 'PRDX1', 'SELENOW', 'SEPHS2', 'MSRB1']",0.18120014250473185,0,0,15
24,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.011258248912178585,inf,inf,"['COX8A', 'GSTP1', 'COX5A']",0.1946738874397547,0,0,3
25,Ciliary landscape WP4352,0.01428128122400065,1.926909949011841,8.187065790779892,"['NUDC', 'NDUFA5', 'SSNA1', 'H3F3A', 'COPS7A', 'MYL6B', 'DYNLL1', 'COX6C', 'LSM4', 'PSMD8', 'MYL6', 'COPS6', 'PSMD7', 'EXOSC4', 'RAB14', 'RANBP10', 'NEFL', 'SNRPB2', 'COPS8', 'DCAF11', 'CALM2']",0.2370692683184108,0,0,21
26,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.021534872467027257,3.472684085510689,13.328445178121449,"['IDI1', 'NSDHL', 'HMGCS1', 'PMVK', 'CYP51A1', 'MSMO1', 'DHCR24']",0.3437296951467812,0,0,7
27,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.02553202375651577,6.936808846761453,25.442978579675323,"['RAB5C', 'RRAS', 'KRAS', 'HRAS']",0.37842106639121587,0,0,4
28,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.02553202375651577,6.936808846761453,25.442978579675323,"['EIF5', 'EIF3I', 'EIF3G', 'EIF1']",0.37842106639121587,0,0,4
29,EGF/EGFR signaling pathway WP437,0.026983635977350894,2.153123460999356,7.778211623922061,"['MAP4K1', 'NDUFA13', 'NEDD8', 'FOXO4', 'CFL1', 'STMN1', 'AP2S1', 'KRAS', 'HRAS', 'MEF2D', 'AP2M1', 'MAPK4', 'ARF6']",0.3815983834839069,0,0,13
30,Ras signaling WP4223,0.027585425312089653,2.007508427827153,7.207894195974943,"['SHC3', 'RAB5C', 'RASA4B', 'BAD', 'FOXO4', 'GNG10', 'GNG3', 'RRAS', 'RAC3', 'CALM3', 'KRAS', 'IKBKG', 'CALM2', 'HRAS', 'ARF6']",0.3815983834839069,0,0,15
31,Photodynamic therapy-induced unfolded protein response WP3613,0.03142298461007306,4.336956521739131,15.00680487279883,"['NARS', 'XBP1', 'DDIT3', 'DNAJB9', 'HSP90B1']",0.4206625359090426,0,0,5
32,Glycolysis and Gluconeogenesis WP534,0.03645244679460582,2.3164021164021165,7.671337054111249,"['LDHA', 'TPI1', 'PKM', 'GOT1', 'MPC2', 'PGAM1', 'PGK1', 'ALDOA', 'PFKM', 'GAPDH']",0.47124625898502165,0,0,10
33,Mevalonate arm of cholesterol biosynthesis pathway WP4190,0.03747259408796558,10.39936858721389,34.15303889867258,"['IDI1', 'HMGCS1', 'PMVK']",0.47124625898502165,0,0,3
34,Melanoma WP4685,0.04368766480853116,2.5252845411324016,7.905881763480251,"['GADD45B', 'BAD', 'GADD45A', 'BAX', 'KRAS', 'CALM3', 'HRAS', 'CALM2']",0.48509489643733417,0,0,8
35,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.0471947041992848,2.699744875516847,8.24359968213148,"['GADD45B', 'BAD', 'GADD45A', 'RAC3', 'CYCS', 'BAX', 'KRAS']",0.48509489643733417,0,0,7
36,Cytosolic DNA-sensing pathway WP4655,0.0471947041992848,2.699744875516847,8.24359968213148,"['IRF3', 'POLR2E', 'POLR3H', 'IKBKG', 'POLR3K', 'POLR2K', 'POLR2L']",0.48509489643733417,0,0,7
37,Fatty acid transporters WP5061,0.04910755865292755,4.6234860452869935,13.93399552352288,"['FABP3', 'FABP5', 'FABP6', 'DBI']",0.48509489643733417,0,0,4
38,Glycolysis in senescence WP5049,0.04910755865292755,4.6234860452869935,13.93399552352288,"['LDHA', 'PKM', 'PGK1', 'GAPDH']",0.48509489643733417,0,0,4
39,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.04910755865292755,4.6234860452869935,13.93399552352288,"['BAD', 'KRAS', 'FOXO4', 'HRAS']",0.48509489643733417,0,0,4
40,Cytosine methylation WP3585,0.05026284469109728,inf,inf,"['TDG', 'TET3']",0.48509489643733417,0,0,2
41,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.05026284469109728,inf,inf,"['ELOB', 'ELOC']",0.48509489643733417,0,0,2
42,Hippo-Yap signaling pathway WP4537,0.05026284469109728,inf,inf,"['MAP4K1', 'YWHAQ']",0.48509489643733417,0,0,2
43,Mevalonate pathway WP3963,0.05026284469109728,inf,inf,"['HMGCS1', 'PMVK']",0.48509489643733417,0,0,2
44,Amyotrophic lateral sclerosis (ALS) WP2447,0.05145700158900836,3.468774703557312,10.291884864815971,"['BAD', 'NEFL', 'BAX', 'NEFH', 'SOD1']",0.4853330831690561,0,0,5
45,DNA Replication WP466,0.07152581593815632,2.6018591772151898,6.8629157100322695,"['POLD4', 'RFC3', 'POLD2', 'RPA2', 'POLE', 'UBA52']",0.6238011548123226,0,0,6
46,Ferroptosis WP4313,0.07152581593815632,2.6018591772151898,6.8629157100322695,"['MAP1LC3B', 'MAP1LC3A', 'GPX4', 'FTH1', 'VDAC2', 'FTL']",0.6238011548123226,0,0,6
47,Metabolic reprogramming in colon cancer WP4290,0.07716396795825485,2.1358039741557966,5.471551033685448,"['ACLY', 'LDHA', 'PKM', 'PGAM1', 'PGK1', 'PYCR1', 'PYCR2', 'GAPDH']",0.6238011548123226,0,0,8
48,G13 Signaling Pathway WP524,0.07737519889835925,2.8899868247694336,7.395733428110669,"['CFL2', 'ARHGDIB', 'CFL1', 'ARHGDIG', 'CALM2']",0.6238011548123226,0,0,5
49,Cholesterol Biosynthesis with Skeletal Dysplasias WP4804,0.07816303626564042,5.198500394632991,13.250761379332813,"['NSDHL', 'CYP51A1', 'DHCR24']",0.6238011548123226,0,0,3
50,HIF1A and PPARG regulation of glycolysis WP2456,0.07816303626564042,5.198500394632991,13.250761379332813,"['LDHA', 'TPI1', 'GAPDH']",0.6238011548123226,0,0,3
51,RalA downstream regulated genes WP2290,0.07816303626564042,5.198500394632991,13.250761379332813,"['RAC3', 'KRAS', 'HRAS']",0.6238011548123226,0,0,3
52,SARS-CoV-2 mitochondrial interactions WP5038,0.07816303626564042,5.198500394632991,13.250761379332813,"['NDUFB9', 'IRF3', 'PHB']",0.6238011548123226,0,0,3
53,Androgen receptor signaling pathway WP138,0.08672542185148299,1.9524682791435368,4.773800995495232,"['SUMO1', 'PRDX1', 'BAG1', 'RACK1', 'DSTN', 'STUB1', 'PARK7', 'FKBP4', 'RAN']",0.6545200554602251,0,0,9
54,Leptin signaling pathway WP2034,0.08674362180798163,2.2078744691571295,5.397807940199408,"['SOCS3', 'BAD', 'CFL2', 'RPS6', 'BAX', 'IKBKG', 'HRAS']",0.6545200554602251,0,0,7
55,Non-small cell lung cancer WP4255,0.08674362180798163,2.2078744691571295,5.397807940199408,"['GADD45B', 'BAD', 'GADD45A', 'CYCS', 'BAX', 'KRAS', 'HRAS']",0.6545200554602251,0,0,7
56,Alzheimer's disease WP2059,0.10738778446745743,1.8371973690348462,4.099354734100766,"['PSENEN', 'ATP5MD', 'BAD', 'CHP1', 'CYCS', 'CALM3', 'GAPDH', 'HSD17B10', 'CALM2']",0.7553547551524549,0,0,9
57,Small cell lung cancer WP4658,0.10738778446745743,1.8371973690348462,4.099354734100766,"['LAMB3', 'GADD45B', 'LAMC3', 'GADD45A', 'CYCS', 'BAX', 'IKBKG', 'CKS1B', 'SKP1']",0.7553547551524549,0,0,9
58,Synaptic Vesicle Pathway WP2267,0.10738778446745743,1.8371973690348462,4.099354734100766,"['RAB3A', 'CLTC', 'AP2S1', 'SLC17A6', 'PARK7', 'SYP', 'SLC25A4', 'AP2M1', 'VAMP2']",0.7553547551524549,0,0,9
59,TNF-alpha signaling pathway WP231,0.10738778446745743,1.8371973690348462,4.099354734100766,"['DIABLO', 'BAD', 'CDC37', 'BAX', 'KRAS', 'IKBKG', 'TXN', 'HRAS', 'SKP1']",0.7553547551524549,0,0,9
60,Modulators of TCR signaling and T cell activation WP5072,0.11185960857604463,2.0234230667722355,4.432329855780858,"['MAP4K1', 'FIBP', 'NDUFB10', 'ELOB', 'IKBKG', 'RNF7', 'MEF2D']",0.7736956259843087,0,0,7
61,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.12827209823205762,6.927444794952681,14.226211048899764,"['RRAS', 'IKBKG']",0.8565672047274192,0,0,2
62,Peroxiredoxin 2 induced ovarian failure WP4873,0.12827209823205762,6.927444794952681,14.226211048899764,"['STAR', 'BAX']",0.8565672047274192,0,0,2
63,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.13079408368365494,3.4648776637726915,7.048015319186441,"['SOCS3', 'CHI3L1', 'BAX']",0.8565672047274192,0,0,3
64,Regulation of Actin Cytoskeleton WP51,0.13663974753349928,1.652305366591081,3.2887608231377508,"['RRAS', 'CFL2', 'TMSB4X', 'CFL1', 'BRK1', 'RAC3', 'KRAS', 'ARPC5', 'MAPK4', 'ACTG1']",0.8565672047274192,0,0,10
65,DNA damage response WP707,0.14035318053364942,1.8673488032157866,3.666713626743729,"['CCNB1', 'GADD45B', 'GADD45A', 'SESN1', 'RPA2', 'CYCS', 'BAX']",0.8565672047274192,0,0,7
66,G Protein Signaling Pathways WP35,0.14035318053364942,1.8673488032157866,3.666713626743729,"['GNG10', 'GNG3', 'RRAS', 'PRKAR1A', 'KRAS', 'HRAS', 'CALM2']",0.8565672047274192,0,0,7
67,miRNA regulation of DNA damage response WP1530,0.14035318053364942,1.8673488032157866,3.666713626743729,"['CCNB1', 'GADD45B', 'GADD45A', 'SESN1', 'RPA2', 'CYCS', 'BAX']",0.8565672047274192,0,0,7
68,Pancreatic adenocarcinoma pathway WP4263,0.14035318053364942,1.8673488032157866,3.666713626743729,"['GADD45B', 'BAD', 'GADD45A', 'RAC3', 'BAX', 'KRAS', 'IKBKG']",0.8565672047274192,0,0,7
69,Genotoxicity pathway WP4286,0.14579257693806202,2.166501976284585,4.171752019309637,"['RPS27', 'GADD45A', 'BLOC1S2', 'TRIAP1', 'PHLDA3']",0.8643417061327964,0,0,5
70,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.14579257693806202,2.166501976284585,4.171752019309637,"['ACLY', 'IDI1', 'HMGCS1', 'CYP51A1', 'DBI']",0.8643417061327964,0,0,5
71,Insulin Signaling WP481,0.16093897122022383,1.576839826839827,2.880460690369072,"['MAP4K1', 'CAP1', 'SOCS3', 'XBP1', 'SHC3', 'HRAS', 'PFKM', 'VAMP2', 'MAPK4', 'ARF6']",0.894893706662188,0,0,10
72,Endometrial cancer WP4155,0.16152202939075397,1.8909666283084006,3.44744724332226,"['GADD45B', 'BAD', 'GADD45A', 'BAX', 'KRAS', 'HRAS']",0.894893706662188,0,0,6
73,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.16152202939075397,1.8909666283084006,3.44744724332226,"['BAD', 'STMN1', 'BAX', 'KRAS', 'IKBKG', 'HRAS']",0.894893706662188,0,0,6
74,Copper homeostasis WP3286,0.16718823781808273,2.310163243812533,4.132038669076149,"['COX17', 'MT3', 'ATOX1', 'SOD1']",0.894893706662188,0,0,4
75,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.16718823781808273,2.310163243812533,4.132038669076149,"['CFL1', 'BANF1', 'KRAS', 'HRAS']",0.894893706662188,0,0,4
76,Nanomaterial induced apoptosis WP2507,0.16718823781808273,2.310163243812533,4.132038669076149,"['ENDOG', 'DIABLO', 'BAX', 'CYCS']",0.894893706662188,0,0,4
77,Regulation of Microtubule Cytoskeleton WP2038,0.16718823781808273,2.310163243812533,4.132038669076149,"['SPRED1', 'PARD6A', 'CFL2', 'STMN1']",0.894893706662188,0,0,4
78,Hepatitis B infection WP4666,0.18718175546364552,1.507936507936508,2.526811779091074,"['CREB3', 'YWHAQ', 'IRF3', 'YWHAB', 'BAD', 'CYCS', 'BAX', 'KRAS', 'IKBKG', 'HRAS']",0.894893706662188,0,0,10
79,Cell cycle WP179,0.18934409180061518,1.4674955703549826,2.4421904665626406,"['YWHAE', 'CDKN2D', 'ANAPC13', 'CCNB1', 'GADD45B', 'YWHAQ', 'GADD45A', 'YWHAB', 'SKP1', 'ANAPC11', 'YWHAH']",0.894893706662188,0,0,11
80,GABA receptor Signaling WP4159,0.1920589941507621,2.5980662983425415,4.286686485406485,"['GABBR1', 'AP2S1', 'AP2M1']",0.894893706662188,0,0,3
81,Gastric Cancer Network 2 WP2363,0.1920589941507621,2.5980662983425415,4.286686485406485,"['RFC3', 'S100A6', 'COL9A3']",0.894893706662188,0,0,3
82,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.1920589941507621,2.5980662983425415,4.286686485406485,"['MAP4K1', 'YWHAQ', 'ACTG1']",0.894893706662188,0,0,3
83,Methionine De Novo and Salvage Pathway WP3580,0.1920589941507621,2.5980662983425415,4.286686485406485,"['AHCY', 'ODC1', 'TXN']",0.894893706662188,0,0,3
84,TP53 network WP1742,0.1920589941507621,2.5980662983425415,4.286686485406485,"['SUMO1', 'GADD45A', 'BAX']",0.894893706662188,0,0,3
85,Interferon type I signaling pathways WP585,0.2185099804634415,1.97968855788761,3.010955025201525,"['SOCS3', 'RPS6', 'RACK1', 'EIF4B']",0.894893706662188,0,0,4
86,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.2185099804634415,1.97968855788761,3.010955025201525,"['LDHA', 'PKM', 'PGK1', 'BAX']",0.894893706662188,0,0,4
87,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.2185099804634415,1.97968855788761,3.010955025201525,"['CREB3', 'STAR', 'CALM3', 'CALM2']",0.894893706662188,0,0,4
88,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.2190716191935524,3.4629337539432177,5.257968231826672,"['HSD11B2', 'STAR']",0.894893706662188,0,0,2
89,Cysteine and methionine catabolism WP4504,0.2190716191935524,3.4629337539432177,5.257968231826672,"['AHCY', 'GOT1']",0.894893706662188,0,0,2
90,Dual hijack model of Vif in HIV infection WP3300,0.2190716191935524,3.4629337539432177,5.257968231826672,"['ELOB', 'ELOC']",0.894893706662188,0,0,2
91,Glycerophospholipid Biosynthetic Pathway WP2533,0.2190716191935524,3.4629337539432177,5.257968231826672,"['PTPMT1', 'CDIPT']",0.894893706662188,0,0,2
92,Homologous recombination WP186,0.2190716191935524,3.4629337539432177,5.257968231826672,"['POLD4', 'POLD2']",0.894893706662188,0,0,2
93,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.2190716191935524,3.4629337539432177,5.257968231826672,"['IRF3', 'IKBKG']",0.894893706662188,0,0,2
94,Trans-sulfuration pathway WP2333,0.2190716191935524,3.4629337539432177,5.257968231826672,"['AHCY', 'GOT1']",0.894893706662188,0,0,2
95,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.22426251925992183,inf,inf,['MAP1LC3A'],0.894893706662188,0,0,1
96,Insulin signaling in adipocytes (diabetic condition) WP3635,0.22426251925992183,inf,inf,['RPS6'],0.894893706662188,0,0,1
97,Insulin signaling in adipocytes (normal condition) WP3634,0.22426251925992183,inf,inf,['RPS6'],0.894893706662188,0,0,1
98,MED and Pseudoachondroplasia genes WP4789,0.22426251925992183,inf,inf,['COL9A3'],0.894893706662188,0,0,1
99,miRNA Biogenesis WP2338,0.22426251925992183,inf,inf,['RAN'],0.894893706662188,0,0,1
100,Mitochondrial CII Assembly WP4920,0.22426251925992183,inf,inf,['SDHAF1'],0.894893706662188,0,0,1
101,NLR Proteins WP288,0.22426251925992183,inf,inf,['IKBKG'],0.894893706662188,0,0,1
102,Pathways of nucleic acid metabolism and innate immune sensing WP4705,0.22426251925992183,inf,inf,['IRF3'],0.894893706662188,0,0,1
103,SARS coronavirus and innate immunity WP4912,0.22426251925992183,inf,inf,['IRF3'],0.894893706662188,0,0,1
104,The alternative pathway of fetal androgen synthesis WP4524,0.22426251925992183,inf,inf,['STAR'],0.894893706662188,0,0,1
105,Myometrial relaxation and contraction pathways WP289,0.23632925260754253,1.3006972111553785,1.8762938480425644,"['YWHAE', 'YWHAB', 'GSTO1', 'ACTG1', 'RGS4', 'CNN1', 'CREB3', 'GNG3', 'YWHAQ', 'PRKAR1A', 'CRH', 'CALM3', 'IGFBP6', 'CALM2', 'YWHAH']",0.9340632364964777,0,0,15
106,Folate Metabolism WP176,0.239088914354931,1.5993184031158714,2.2884963209766758,"['SERPINA3', 'AHCY', 'GPX4', 'HBA1', 'ICAM1', 'SOD1']",0.9360556552575128,0,0,6
107,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.24291430352010887,1.5161817102137767,2.14546771072259,"['SHC3', 'RRAS', 'BAD', 'RPS6', 'BAX', 'KRAS', 'HRAS']",0.9421442613163101,0,0,7
108,BDNF-TrkB Signaling WP3676,0.2586163593643345,2.0779794790844512,2.810279299232323,"['HOMER1', 'KRAS', 'HRAS']",0.9846402673045764,0,0,3
109,Imatinib and Chronic Myeloid Leukemia WP3640,0.2586163593643345,2.0779794790844512,2.810279299232323,"['SPRED2', 'GADD45A', 'PIM2']",0.9846402673045764,0,0,3
110,CAMKK2  Pathway WP4874,0.2732708884949588,1.731832543443918,2.246692002095413,"['FIS1', 'MAP1LC3A', 'CALM2', 'ICAM1']",0.9935611087965842,0,0,4
111,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.2732708884949588,1.731832543443918,2.246692002095413,"['STAR', 'FSHR', 'KRAS', 'HRAS']",0.9935611087965842,0,0,4
112,Amino Acid metabolism WP3925,0.281404225754773,1.484742314647378,1.882598493990814,"['ACLY', 'LDHA', 'PKM', 'GOT1', 'ODC1', 'PYCR1']",0.9935611087965842,0,0,6
113,p53 transcriptional gene network WP4963,0.281404225754773,1.484742314647378,1.882598493990814,"['SIVA1', 'MGMT', 'GADD45A', 'SESN1', 'BAX', 'ICAM1']",0.9935611087965842,0,0,6
114,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.3130106617852934,2.3080967402733963,2.6808959691415946,"['FSHR', 'RPS6']",0.9935611087965842,0,0,2
115,Nanoparticle-mediated activation of receptor signaling WP2643,0.3130106617852934,2.3080967402733963,2.6808959691415946,"['KRAS', 'HRAS']",0.9935611087965842,0,0,2
116,"Relationship between inflammation, COX-2 and EGFR WP4483",0.3130106617852934,2.3080967402733963,2.6808959691415946,"['KRAS', 'HRAS']",0.9935611087965842,0,0,2
117,Rett syndrome causing genes WP4312,0.3130106617852934,2.3080967402733963,2.6808959691415946,"['EIF2B2', 'IMPDH2']",0.9935611087965842,0,0,2
118,Serotonin and anxiety WP3947,0.3130106617852934,2.3080967402733963,2.6808959691415946,"['POMC', 'CRH']",0.9935611087965842,0,0,2
119,Apoptosis WP254,0.32518679179062887,1.3854430379746836,1.556345081283308,"['IRF3', 'DIABLO', 'BAD', 'CYCS', 'BAX', 'IKBKG']",0.9935611087965842,0,0,6
120,Thermogenesis WP4321,0.32518679179062887,1.3854430379746836,1.556345081283308,"['CREB3', 'RPS6', 'ZNF516', 'KRAS', 'HRAS', 'ACTG1']",0.9935611087965842,0,0,6
121,Canonical and non-canonical Notch signaling WP3845,0.3274766607795919,1.7312549329123914,1.9326665197616948,"['RRAS', 'NOTCH4', 'DLL3']",0.9935611087965842,0,0,3
122,IL-2 signaling pathway WP49,0.3274766607795919,1.7312549329123914,1.9326665197616948,"['SOCS3', 'RPS6', 'HRAS']",0.9935611087965842,0,0,3
123,MAPK Cascade WP422,0.3274766607795919,1.7312549329123914,1.9326665197616948,"['RRAS', 'KRAS', 'HRAS']",0.9935611087965842,0,0,3
124,Notch Signaling WP268,0.3274766607795919,1.7312549329123914,1.9326665197616948,"['NOTCH4', 'DTX3', 'DLL3']",0.9935611087965842,0,0,3
125,p38 MAPK Signaling Pathway WP400,0.3274766607795919,1.7312549329123914,1.9326665197616948,"['DDIT3', 'HRAS', 'MEF2D']",0.9935611087965842,0,0,3
126,Aryl Hydrocarbon Receptor Netpath WP2586,0.329927906290133,1.5390556433210463,1.7066297365450303,"['CDC37', 'AIP', 'KRAS', 'HRAS']",0.9935611087965842,0,0,4
127,MET in type 1 papillary renal cell carcinoma WP4205,0.329927906290133,1.5390556433210463,1.7066297365450303,"['BAD', 'RPL11', 'KRAS', 'HRAS']",0.9935611087965842,0,0,4
128,Notch Signaling Pathway Netpath WP61,0.329927906290133,1.5390556433210463,1.7066297365450303,"['PSENEN', 'NOTCH4', 'SKP1', 'DLL3']",0.9935611087965842,0,0,4
129,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.329927906290133,1.5390556433210463,1.7066297365450303,"['TKFC', 'IRF3', 'PIN1', 'IKBKG']",0.9935611087965842,0,0,4
130,Parkinson's disease pathway WP2371,0.329927906290133,1.5390556433210463,1.7066297365450303,"['PINK1', 'SYT11', 'CYCS', 'PARK7']",0.9935611087965842,0,0,4
131,G1 to S cell cycle control WP45,0.36977738218835426,1.298556170886076,1.2918739620866455,"['CDKN2D', 'CREB3', 'CCNB1', 'GADD45A', 'RPA2', 'POLE']",0.9935611087965842,0,0,6
132,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.36977738218835426,1.298556170886076,1.2918739620866455,"['POMC', 'CREB3', 'BAD', 'RPS6', 'ZNF516', 'HRAS']",0.9935611087965842,0,0,6
133,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.3870782940906556,1.3848341232227488,1.3143852517590835,"['XBP1', 'MAP1LC3A', 'PPP1R11', 'DDIT3']",0.9935611087965842,0,0,4
134,Interleukin-11 Signaling Pathway WP2332,0.3870782940906556,1.3848341232227488,1.3143852517590835,"['SOCS3', 'RPS6', 'HRAS', 'ICAM1']",0.9935611087965842,0,0,4
135,NO/cGMP/PKG mediated Neuroprotection WP4008,0.3870782940906556,1.3848341232227488,1.3143852517590835,"['BAD', 'NEFL', 'CYCS', 'CALM2']",0.9935611087965842,0,0,4
136,Integrated breast cancer pathway WP1984,0.39225514280225404,1.2044374009508716,1.1271640413336455,"['RRAS', 'GADD45A', 'BAD', 'ODC1', 'BAX', 'KRAS', 'PHB', 'FAU']",0.9935611087965842,0,0,8
137,7-oxo-C and 7beta-HC pathways WP5064,0.39617167816936494,1.4835945427894914,1.3736715083960098,"['HSD11B2', 'THEM5', 'ACOT4']",0.9935611087965842,0,0,3
138,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.39617167816936494,1.4835945427894914,1.3736715083960098,"['H3F3B', 'H2AFZ', 'H3F3A']",0.9935611087965842,0,0,3
139,Histone Modifications WP2369,0.39617167816936494,1.4835945427894914,1.3736715083960098,"['SET', 'H3F3B', 'H3F3A']",0.9935611087965842,0,0,3
140,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.39617167816936494,1.4835945427894914,1.3736715083960098,"['IFITM3', 'IFITM2', 'DDIT3']",0.9935611087965842,0,0,3
141,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.39617167816936494,1.4835945427894914,1.3736715083960098,"['MAP1LC3A', 'ATG101', 'FTL']",0.9935611087965842,0,0,3
142,Acetylcholine Synthesis WP528,0.3982620582455103,3.4609929078014185,3.1863459975471424,['CHKA'],0.9935611087965842,0,0,1
143,Cell Differentiation - Index WP2029,0.3982620582455103,3.4609929078014185,3.1863459975471424,['MEF2D'],0.9935611087965842,0,0,1
144,Effects of nitric oxide WP1995,0.3982620582455103,3.4609929078014185,3.1863459975471424,['HBA1'],0.9935611087965842,0,0,1
145,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.3982620582455103,3.4609929078014185,3.1863459975471424,['GABBR1'],0.9935611087965842,0,0,1
146,Heme Biosynthesis WP561,0.3982620582455103,3.4609929078014185,3.1863459975471424,['UROD'],0.9935611087965842,0,0,1
147,Kennedy pathway from sphingolipids WP3933,0.3982620582455103,3.4609929078014185,3.1863459975471424,['CHKA'],0.9935611087965842,0,0,1
148,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.3982620582455103,3.4609929078014185,3.1863459975471424,['AHCY'],0.9935611087965842,0,0,1
149,Mitochondrial fatty acid synthesis pathway WP4317,0.3982620582455103,3.4609929078014185,3.1863459975471424,['MCAT'],0.9935611087965842,0,0,1
150,Molybdenum cofactor (Moco) biosynthesis WP4507,0.3982620582455103,3.4609929078014185,3.1863459975471424,['MOCS2'],0.9935611087965842,0,0,1
151,Nanoparticle triggered autophagic cell death WP2509,0.3982620582455103,3.4609929078014185,3.1863459975471424,['MAP1LC3A'],0.9935611087965842,0,0,1
152,Purine metabolism WP4792,0.3982620582455103,3.4609929078014185,3.1863459975471424,['APRT'],0.9935611087965842,0,0,1
153,SARS-CoV-2 and angiotensin-converting enzyme 2 receptor: molecular mechanisms WP4883,0.3982620582455103,3.4609929078014185,3.1863459975471424,['MAS1'],0.9935611087965842,0,0,1
154,TCA cycle in senescence WP5050,0.3982620582455103,3.4609929078014185,3.1863459975471424,['GOT1'],0.9935611087965842,0,0,1
155,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.3982620582455103,3.4609929078014185,3.1863459975471424,['IRF3'],0.9935611087965842,0,0,1
156,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.40411891953378504,1.7306782334384858,1.568074244816713,"['H3F3B', 'H3F3A']",0.9935611087965842,0,0,2
157,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.40411891953378504,1.7306782334384858,1.568074244816713,"['CD63', 'SOD1']",0.9935611087965842,0,0,2
158,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.40411891953378504,1.7306782334384858,1.568074244816713,"['BAD', 'BAX']",0.9935611087965842,0,0,2
159,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.40411891953378504,1.7306782334384858,1.568074244816713,"['KRAS', 'HRAS']",0.9935611087965842,0,0,2
160,Splicing factor NOVA regulated synaptic proteins WP4148,0.40411891953378504,1.7306782334384858,1.568074244816713,"['APLP2', 'MAPK4']",0.9935611087965842,0,0,2
161,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.40411891953378504,1.7306782334384858,1.568074244816713,"['IRF3', 'IKBKG']",0.9935611087965842,0,0,2
162,TLR4 Signaling and Tolerance WP3851,0.40411891953378504,1.7306782334384858,1.568074244816713,"['IRF3', 'IKBKG']",0.9935611087965842,0,0,2
163,Tumor suppressor activity of SMARCB1 WP4204,0.40411891953378504,1.7306782334384858,1.568074244816713,"['H3F3B', 'H3F3A']",0.9935611087965842,0,0,2
164,Retinoblastoma gene in cancer WP2446,0.41455257240935,1.221891288160834,1.0759430686958436,"['RFC3', 'CCNB1', 'H2AFZ', 'STMN1', 'RPA2', 'POLE']",0.9935611087965842,0,0,6
165,Pathways in clear cell renal cell carcinoma WP4018,0.4302980828826651,1.1539883782356049,0.9731319666293923,"['ACLY', 'LDHA', 'TPI1', 'PKM', 'PGK1', 'ALDOA', 'GAPDH', 'PFKM']",0.9935611087965842,0,0,8
166,IL-3 signaling pathway WP286,0.44351406087634987,1.2586528795059602,1.0233172307918446,"['YWHAQ', 'YWHAB', 'BAD', 'HRAS']",0.9935611087965842,0,0,4
167,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.4437074102050533,1.1538664555291633,0.937620250559848,"['PSMD8', 'HSPA8', 'PSMC5', 'TUBA1A', 'PSMD7', 'PSMC3', 'STUB1']",0.9935611087965842,0,0,7
168,IL-18 signaling pathway WP4754,0.45891477612775333,1.0536429143314652,0.8206727293484067,"['NRN1', 'IMP3', 'BAD', 'COX17', 'NDUFC1', 'BPGM', 'RND2', 'ICAM1', 'PTMS', 'SOCS3', 'ARL4D', 'NACA', 'TMSB4X', 'STMN1', 'CYCS', 'BAX', 'RPS11', 'STK40', 'AARS', 'ITM2C', 'ARF6']",0.9935611087965842,0,0,21
169,Endothelin Pathways WP2197,0.4627947859914244,1.2978492501973165,0.9999559234013795,"['CNN1', 'RIIAD1', 'CALM2']",0.9935611087965842,0,0,3
170,Kit receptor signaling pathway WP304,0.4627947859914244,1.2978492501973165,0.9999559234013795,"['BAD', 'RPS6', 'HRAS']",0.9935611087965842,0,0,3
171,miRNA regulation of prostate cancer signaling pathways WP3981,0.4627947859914244,1.2978492501973165,0.9999559234013795,"['BAD', 'KRAS', 'IKBKG']",0.9935611087965842,0,0,3
172,One-carbon metabolism and related pathways WP3940,0.4627947859914244,1.2978492501973165,0.9999559234013795,"['GPX4', 'CHKA', 'SOD1']",0.9935611087965842,0,0,3
173,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.4627947859914244,1.2978492501973165,0.9999559234013795,"['HOMER1', 'KRAS', 'HRAS']",0.9935611087965842,0,0,3
174,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.4627947859914244,1.2978492501973165,0.9999559234013795,"['RPS6', 'PIM2', 'EIF4B']",0.9935611087965842,0,0,3
175,Urea cycle and metabolism of amino groups WP497,0.4627947859914244,1.2978492501973165,0.9999559234013795,"['GAMT', 'ODC1', 'PYCR1']",0.9935611087965842,0,0,3
176,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.47671264357618554,1.153623188405797,0.8546518110410255,"['MAP4K1', 'CAP1', 'SHC3', 'HRAS', 'MAPK4']",0.9935611087965842,0,0,5
177,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.47671264357618554,1.153623188405797,0.8546518110410255,"['TMSB4X', 'NEFL', 'NEFH', 'PFN2', 'SOD1']",0.9935611087965842,0,0,5
178,Pathogenic Escherichia coli infection WP2272,0.47671264357618554,1.153623188405797,0.8546518110410255,"['TUBA1A', 'YWHAQ', 'ARPC5L', 'ARPC5', 'ACTG1']",0.9935611087965842,0,0,5
179,Biomarkers for urea cycle disorders WP4583,0.48894284651351844,1.3842271293375394,0.9904279029312061,"['GAMT', 'GOT1']",0.9935611087965842,0,0,2
180,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.48894284651351844,1.3842271293375394,0.9904279029312061,"['KRAS', 'HRAS']",0.9935611087965842,0,0,2
181,Lipid Metabolism Pathway WP3965,0.48894284651351844,1.3842271293375394,0.9904279029312061,"['ACLY', 'PRKAR1A']",0.9935611087965842,0,0,2
182,miRNAs involvement in the immune response in sepsis WP4329,0.48894284651351844,1.3842271293375394,0.9904279029312061,"['IKBKG', 'ICAM1']",0.9935611087965842,0,0,2
183,MTHFR deficiency WP4288,0.48894284651351844,1.3842271293375394,0.9904279029312061,"['CHKA', 'CYCS']",0.9935611087965842,0,0,2
184,Nucleotide metabolism WP404,0.48894284651351844,1.3842271293375394,0.9904279029312061,"['NME2', 'OAZ1']",0.9935611087965842,0,0,2
185,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.48894284651351844,1.3842271293375394,0.9904279029312061,"['YWHAQ', 'FOXO4']",0.9935611087965842,0,0,2
186,Senescence and Autophagy in Cancer WP615,0.4890544552638992,1.0740244469359292,0.7682297478973915,"['GABARAPL2', 'GABARAPL1', 'MAP1LC3B', 'SPARC', 'MAP1LC3A', 'HMGA1', 'ING1', 'HRAS', 'GABARAP']",0.9935611087965842,0,0,9
187,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.49824616127421784,1.1535018430753028,0.8035997755702305,"['BEX3', 'SOCS3', 'SERBP1', 'RNF7']",0.9935611087965842,0,0,4
188,Sleep regulation WP3591,0.49824616127421784,1.1535018430753028,0.8035997755702305,"['AHCY', 'STAR', 'CRH', 'HCRTR1']",0.9935611087965842,0,0,4
189,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.49824616127421784,1.1535018430753028,0.8035997755702305,"['APEX1', 'RPS6', 'HRAS', 'MYL12B']",0.9935611087965842,0,0,4
190,Vitamin B12 metabolism WP1533,0.49824616127421784,1.1535018430753028,0.8035997755702305,"['SERPINA3', 'HBA1', 'ICAM1', 'SOD1']",0.9935611087965842,0,0,4
191,Fragile X Syndrome  WP4549,0.5235909532039192,1.0530482977038798,0.6813691336554587,"['DUSP3', 'HOMER1', 'PRKAR1A', 'CLTC', 'AP2S1', 'KRAS', 'AP2M1']",0.9935611087965842,0,0,7
192,TGF-beta Signaling Pathway WP366,0.5235909532039192,1.0530482977038798,0.6813691336554587,"['MAP4K1', 'PARD6A', 'CITED1', 'SUMO1', 'STRAP', 'MAPK4', 'SKP1']",0.9935611087965842,0,0,7
193,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.5239745558785738,1.0286155893780993,0.6648067565132713,"['YWHAE', 'YWHAQ', 'PRKAR1A', 'YWHAB', 'ATP1A3', 'ALDOA', 'GAPDH', 'SLC25A4', 'VAMP2', 'HSP90B1', 'YWHAH']",0.9935611087965842,0,0,11
194,DNA damage response (only ATM dependent) WP710,0.5240644479728456,1.0812747035573123,0.6986554964361692,"['BAD', 'RAC3', 'BAX', 'KRAS', 'HRAS']",0.9935611087965842,0,0,5
195,AGE/RAGE pathway WP2324,0.5259693835441769,1.1533806892922915,0.7410612496127998,"['CYCS', 'FOXO4', 'SOD1']",0.9935611087965842,0,0,3
196,ATM Signaling Pathway WP2516,0.5259693835441769,1.1533806892922915,0.7410612496127998,"['CCNB1', 'GADD45A', 'IKBKG']",0.9935611087965842,0,0,3
197,IL-5 signaling pathway WP127,0.5259693835441769,1.1533806892922915,0.7410612496127998,"['SPRED1', 'RPS6', 'KRAS']",0.9935611087965842,0,0,3
198,Type II interferon signaling (IFNG) WP619,0.5259693835441769,1.1533806892922915,0.7410612496127998,"['SOCS3', 'HLA-B', 'ICAM1']",0.9935611087965842,0,0,3
199,Canonical NF-KB pathway WP4562,0.5332569319773246,1.7301024428684004,1.0878052366022979,['IKBKG'],0.9935611087965842,0,0,1
200,Gastric acid production WP2596,0.5332569319773246,1.7301024428684004,1.0878052366022979,['CCK'],0.9935611087965842,0,0,1
201,Glycerolipids and Glycerophospholipids WP4722,0.5332569319773246,1.7301024428684004,1.0878052366022979,['CDIPT'],0.9935611087965842,0,0,1
202,Iron metabolism in placenta WP2007,0.5332569319773246,1.7301024428684004,1.0878052366022979,['FTH1'],0.9935611087965842,0,0,1
203,Nanoparticle triggered regulated necrosis WP2513,0.5332569319773246,1.7301024428684004,1.0878052366022979,['FTL'],0.9935611087965842,0,0,1
204,Role of Altered Glycolysation of MUC1 in Tumour Microenvironment WP4480,0.5332569319773246,1.7301024428684004,1.0878052366022979,['IKBKG'],0.9935611087965842,0,0,1
205,Serotonin and anxiety-related events WP3944,0.5332569319773246,1.7301024428684004,1.0878052366022979,['CRH'],0.9935611087965842,0,0,1
206,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.5332569319773246,1.7301024428684004,1.0878052366022979,['DLL3'],0.9935611087965842,0,0,1
207,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.5332569319773246,1.7301024428684004,1.0878052366022979,['HMGCS1'],0.9935611087965842,0,0,1
208,SRF and miRs in Smooth Muscle Differentiation and Proliferation WP1991,0.5332569319773246,1.7301024428684004,1.0878052366022979,['MEF2D'],0.9935611087965842,0,0,1
209,Statin inhibition of cholesterol production WP430,0.5332569319773246,1.7301024428684004,1.0878052366022979,['APOC1'],0.9935611087965842,0,0,1
210,Supression of HMGB1 mediated inflammation by THBD WP4479,0.5332569319773246,1.7301024428684004,1.0878052366022979,['IKBKG'],0.9935611087965842,0,0,1
211,Valproic acid pathway WP3871,0.5332569319773246,1.7301024428684004,1.0878052366022979,['HSD17B10'],0.9935611087965842,0,0,1
212,Acute viral myocarditis WP4298,0.5505067362234423,1.064527889172439,0.6354338214039796,"['ENDOG', 'RAC3', 'CYCS', 'BAX']",0.9935611087965842,0,0,4
213,ErbB signaling pathway WP673,0.5505067362234423,1.064527889172439,0.6354338214039796,"['SHC3', 'BAD', 'KRAS', 'HRAS']",0.9935611087965842,0,0,4
214,PPAR signaling pathway WP3942,0.5505067362234423,1.064527889172439,0.6354338214039796,"['FABP3', 'FABP5', 'FABP6', 'DBI']",0.9935611087965842,0,0,4
215,Prostaglandin Synthesis and Regulation WP98,0.5505067362234423,1.064527889172439,0.6354338214039796,"['HSD11B2', 'ANXA6', 'S100A6', 'PTGES']",0.9935611087965842,0,0,4
216,Breast cancer pathway WP4262,0.5574288204104495,1.0042720830881788,0.5869171529573767,"['SHC3', 'GADD45B', 'GADD45A', 'NOTCH4', 'BAX', 'KRAS', 'HRAS', 'SKP1', 'DLL3']",0.9935611087965842,0,0,9
217,22q11.2 copy number variation syndrome WP4657,0.5618972100968521,1.008940353655318,0.5815898907932832,"['RANBP1', 'CYP26B1', 'MRPL40', 'THAP7', 'DGCR6L', 'EMC10', 'RAN']",0.9935611087965842,0,0,7
218,Autophagy WP4923,0.5657182910985088,1.1532597266035751,0.6569648328671103,"['MAP1LC3B', 'ATG101']",0.9935611087965842,0,0,2
219,Galanin receptor pathway WP4970,0.5657182910985088,1.1532597266035751,0.6569648328671103,"['POMC', 'VAMP2']",0.9935611087965842,0,0,2
220,Glycosylation and related congenital defects WP4521,0.5657182910985088,1.1532597266035751,0.6569648328671103,"['DPM2', 'DPM3']",0.9935611087965842,0,0,2
221,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.5657182910985088,1.1532597266035751,0.6569648328671103,"['LDHA', 'RPS6']",0.9935611087965842,0,0,2
222,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.5657182910985088,1.1532597266035751,0.6569648328671103,"['GOT1', 'HMGA1']",0.9935611087965842,0,0,2
223,PDGF Pathway WP2526,0.5657182910985088,1.1532597266035751,0.6569648328671103,"['ARFIP2', 'HRAS']",0.9935611087965842,0,0,2
224,Signaling of Hepatocyte Growth Factor Receptor WP313,0.5657182910985088,1.1532597266035751,0.6569648328671103,"['MAP4K1', 'HRAS']",0.9935611087965842,0,0,2
225,Toll-like Receptor Signaling related to MyD88 WP3858,0.5657182910985088,1.1532597266035751,0.6569648328671103,"['IRF3', 'IKBKG']",0.9935611087965842,0,0,2
226,Unfolded protein response WP4925,0.5657182910985088,1.1532597266035751,0.6569648328671103,"['XBP1', 'DDIT3']",0.9935611087965842,0,0,2
227,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.5768760519344841,0.9882273035997283,0.5436513620596253,"['RAB3A', 'SHC3', 'BAD', 'CFL1', 'RPS6', 'RACK1', 'IKBKG', 'HRAS']",0.9935611087965842,0,0,8
228,Fas ligand pathway and stress induction of heat shock proteins WP314,0.5847817868273356,1.0378058405682715,0.5567999731476293,"['ARHGDIB', 'CYCS', 'ACTG1']",0.9935611087965842,0,0,3
229,16p11.2 proximal deletion syndrome WP4949,0.5851550423623207,0.9882459312839059,0.5295796852111125,"['TMEM219', 'ALDOA', 'SEZ6L2', 'CCT7', 'CDIPT', 'CCT4']",0.9935611087965842,0,0,6
230,Exercise-induced Circadian Regulation WP410,0.5851550423623207,0.9882459312839059,0.5295796852111125,"['DNAJA1', 'IDI1', 'HSPA8', 'SUMO1', 'GSTP1', 'STBD1']",0.9935611087965842,0,0,6
231,Head and Neck Squamous Cell Carcinoma WP4674,0.5997365581602448,0.9882645001128414,0.5052648420338616,"['SESN1', 'RPS6', 'KRAS', 'HRAS']",0.9935611087965842,0,0,4
232,Integrin-mediated Cell Adhesion WP185,0.5997365581602448,0.9882645001128414,0.5052648420338616,"['SHC3', 'RAC3', 'HRAS', 'MAPK4']",0.9935611087965842,0,0,4
233,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.5997365581602448,0.9882645001128414,0.5052648420338616,"['RRAS', 'CHP1', 'IKBKG', 'CALM2']",0.9935611087965842,0,0,4
234,Chemokine signaling pathway WP3929,0.6237316423734512,0.9431098964326813,0.4451809397690831,"['GNG10', 'GNG3', 'SHC3', 'KRAS', 'IKBKG', 'HRAS']",0.9935611087965842,0,0,6
235,Alpha 6 Beta 4 signaling pathway WP244,0.6337872717441192,0.9882830103650293,0.4506984759916557,"['LAMB3', 'HRAS']",0.9935611087965842,0,0,2
236,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.6337872717441192,0.9882830103650293,0.4506984759916557,"['MAP1LC3A', 'EIF2B2']",0.9935611087965842,0,0,2
237,Pre-implantation embryo WP3527,0.6337872717441192,0.9882830103650293,0.4506984759916557,"['DDIT3', 'HMGA1']",0.9935611087965842,0,0,2
238,ACE Inhibitor Pathway WP554,0.6379852719274312,1.1531389545573942,0.518266864745058,['MAS1'],0.9935611087965842,0,0,1
239,Alanine and aspartate metabolism WP106,0.6379852719274312,1.1531389545573942,0.518266864745058,['GOT1'],0.9935611087965842,0,0,1
240,Cannabinoid receptor signaling WP3869,0.6379852719274312,1.1531389545573942,0.518266864745058,['PRKAR1A'],0.9935611087965842,0,0,1
241,Dopamine metabolism WP2436,0.6379852719274312,1.1531389545573942,0.518266864745058,['SOD1'],0.9935611087965842,0,0,1
242,Ebstein-Barr virus LMP1 signaling WP262,0.6379852719274312,1.1531389545573942,0.518266864745058,['IKBKG'],0.9935611087965842,0,0,1
243,Genes targeted by miRNAs in adipocytes WP1992,0.6379852719274312,1.1531389545573942,0.518266864745058,['TMSB4X'],0.9935611087965842,0,0,1
244,Kallmann's Syndrome WP5074,0.6379852719274312,1.1531389545573942,0.518266864745058,['GNRH1'],0.9935611087965842,0,0,1
245,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.6379852719274312,1.1531389545573942,0.518266864745058,['VEGFB'],0.9935611087965842,0,0,1
246,PPAR-alpha pathway WP2878,0.6379852719274312,1.1531389545573942,0.518266864745058,['DBI'],0.9935611087965842,0,0,1
247,Purine metabolism and related disorders WP4224,0.6379852719274312,1.1531389545573942,0.518266864745058,['APRT'],0.9935611087965842,0,0,1
248,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.6379852719274312,1.1531389545573942,0.518266864745058,['BAX'],0.9935611087965842,0,0,1
249,Signal Transduction of S1P Receptor WP26,0.6379852719274312,1.1531389545573942,0.518266864745058,['MAPK4'],0.9935611087965842,0,0,1
250,Sulfation Biotransformation Reaction WP692,0.6379852719274312,1.1531389545573942,0.518266864745058,['SULT4A1'],0.9935611087965842,0,0,1
251,TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,0.6379852719274312,1.1531389545573942,0.518266864745058,['ACLY'],0.9935611087965842,0,0,1
252,Vitamin D in inflammatory diseases WP4482,0.6379852719274312,1.1531389545573942,0.518266864745058,['IKBKG'],0.9935611087965842,0,0,1
253,Aryl Hydrocarbon Receptor Pathway WP2873,0.6387008774520831,0.9432446007031643,0.4228745182171114,"['CDC37', 'AIP', 'BAX']",0.9935611087965842,0,0,3
254,Cardiac Hypertrophic Response WP2795,0.6387008774520831,0.9432446007031643,0.4228745182171114,"['MAP4K1', 'IKBKG', 'CALM2']",0.9935611087965842,0,0,3
255,DNA IR-damage and cellular response via ATR WP4016,0.6387008774520831,0.9432446007031643,0.4228745182171114,"['FEN1', 'RPA2', 'IKBKG']",0.9935611087965842,0,0,3
256,Regulatory circuits of the STAT3 signaling pathway WP4538,0.6455634556899041,0.9221695629278568,0.4035706969739191,"['IL15RA', 'SOCS3', 'STMN1', 'MAPK4']",0.9935611087965842,0,0,4
257,Focal Adhesion WP306,0.6519775513679047,0.9150300881653216,0.3913996805467075,"['SHC3', 'LAMB3', 'LAMC3', 'BAD', 'VEGFB', 'RAC3', 'HRAS', 'MYL12B', 'ACTG1']",0.9935611087965842,0,0,9
258,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.6672750617201458,0.8962200521978828,0.36256844955367407,"['SPARC', 'NOTCH4', 'STRAP', 'KRAS', 'HRAS', 'MEF2D', 'DLL3']",0.9935611087965842,0,0,7
259,Circadian rhythm related genes WP3594,0.6819150343717016,0.898313444709626,0.34391949268887745,"['OPN4', 'AHCY', 'HOMER1', 'CAVIN3', 'OPRL1', 'NR2F6', 'HCRTR1', 'RAI1', 'STAR', 'CRH', 'RPS27A', 'UBA52', 'SKP1']",0.9935611087965842,0,0,13
260,IL-6 signaling pathway WP364,0.6874975347491483,0.8644435674822415,0.32390444189144985,"['SOCS3', 'BAD', 'NR2F6']",0.9935611087965842,0,0,3
261,MECP2 and Associated Rett Syndrome WP3584,0.6874975347491483,0.8644435674822415,0.32390444189144985,"['GAMT', 'RPS6', 'TET3']",0.9935611087965842,0,0,3
262,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.6874975347491483,0.8644435674822415,0.32390444189144985,"['IFI27L2', 'KRAS', 'HRAS']",0.9935611087965842,0,0,3
263,Oxidative Damage WP3941,0.6874975347491483,0.8644435674822415,0.32390444189144985,"['BAD', 'GADD45A', 'CYCS']",0.9935611087965842,0,0,3
264,Oncostatin M Signaling Pathway WP2374,0.6877761196074661,0.8643364928909952,0.32351414950548074,"['SOCS3', 'RPS6', 'KRAS', 'HRAS']",0.9935611087965842,0,0,4
265,Prolactin Signaling Pathway WP2037,0.6877761196074661,0.8643364928909952,0.32351414950548074,"['SOCS3', 'RPS6', 'PPIB', 'HRAS']",0.9935611087965842,0,0,4
266,B Cell Receptor Signaling Pathway WP23,0.6904749174356183,0.8642292490118577,0.32008945430647756,"['MAP4K1', 'IKBKG', 'HRAS', 'MEF2D', 'MAPK4']",0.9935611087965842,0,0,5
267,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.6931911096297894,0.8645504731861199,0.31681412868590947,"['IRF3', 'IKBKG']",0.9935611087965842,0,0,2
268,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.6931911096297894,0.8645504731861199,0.31681412868590947,"['RAB3A', 'NEFL']",0.9935611087965842,0,0,2
269,Oxidative Stress WP408,0.6931911096297894,0.8645504731861199,0.31681412868590947,"['TXN2', 'SOD1']",0.9935611087965842,0,0,2
270,White fat cell differentiation WP4149,0.6931911096297894,0.8645504731861199,0.31681412868590947,"['IRF3', 'DDIT3']",0.9935611087965842,0,0,2
271,Ebola Virus Pathway on Host WP4217,0.6943023768945288,0.864121835443038,0.3152728743679336,"['SOCS3', 'IRF3', 'CLTC', 'HLA-B', 'HLA-DRB1', 'ACTG1']",0.9935611087965842,0,0,6
272,Adipogenesis WP236,0.6986861292809069,0.8640142517814727,0.30979547728151957,"['SOCS3', 'CYP26B1', 'GADD45B', 'GADD45A', 'DDIT3', 'HMGA1', 'MEF2D']",0.9935611087965842,0,0,7
273,Airway smooth muscle cell contraction WP4962,0.7192288292241678,0.8646572104018913,0.2849700153217745,['CALM2'],0.9935611087965842,0,0,1
274,Apoptosis Modulation by HSP70 WP384,0.7192288292241678,0.8646572104018913,0.2849700153217745,['CYCS'],0.9935611087965842,0,0,1
275,Cancer immunotherapy by CTLA4 blockade WP4582,0.7192288292241678,0.8646572104018913,0.2849700153217745,['HLA-DRB1'],0.9935611087965842,0,0,1
276,Cell Differentiation - Index expanded WP2023,0.7192288292241678,0.8646572104018913,0.2849700153217745,['MEF2D'],0.9935611087965842,0,0,1
277,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.7192288292241678,0.8646572104018913,0.2849700153217745,['CCK'],0.9935611087965842,0,0,1
278,Cells and molecules involved in local acute inflammatory response  WP4493,0.7192288292241678,0.8646572104018913,0.2849700153217745,['ICAM1'],0.9935611087965842,0,0,1
279,EPO Receptor Signaling WP581,0.7192288292241678,0.8646572104018913,0.2849700153217745,['EPOR'],0.9935611087965842,0,0,1
280,Ethanol effects on histone modifications WP3996,0.7192288292241678,0.8646572104018913,0.2849700153217745,['AHCY'],0.9935611087965842,0,0,1
281,Glutathione metabolism WP100,0.7192288292241678,0.8646572104018913,0.2849700153217745,['GPX4'],0.9935611087965842,0,0,1
282,IL17 signaling pathway WP2112,0.7192288292241678,0.8646572104018913,0.2849700153217745,['IKBKG'],0.9935611087965842,0,0,1
283,Leptin Insulin Overlap WP3935,0.7192288292241678,0.8646572104018913,0.2849700153217745,['SOCS3'],0.9935611087965842,0,0,1
284,NOTCH1 regulation of endothelial cell calcification WP3413,0.7192288292241678,0.8646572104018913,0.2849700153217745,['DLL3'],0.9935611087965842,0,0,1
285,PDGFR-beta pathway WP3972,0.7192288292241678,0.8646572104018913,0.2849700153217745,['HRAS'],0.9935611087965842,0,0,1
286,Physiological and pathological hypertrophy of the heart WP1528,0.7192288292241678,0.8646572104018913,0.2849700153217745,['CALM2'],0.9935611087965842,0,0,1
287,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.7192288292241678,0.8646572104018913,0.2849700153217745,['ANAPC11'],0.9935611087965842,0,0,1
288,Role of Osx and miRNAs in tooth development WP3971,0.7192288292241678,0.8646572104018913,0.2849700153217745,['NOTCH4'],0.9935611087965842,0,0,1
289,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.7192288292241678,0.8646572104018913,0.2849700153217745,['IDH3B'],0.9935611087965842,0,0,1
290,Trans-sulfuration and one-carbon metabolism WP2525,0.7192288292241678,0.8646572104018913,0.2849700153217745,['AHCY'],0.9935611087965842,0,0,1
291,Gastrin signaling pathway WP4659,0.7251987570608752,0.8228872576698664,0.26440150486247527,"['BAD', 'RPS6', 'KRAS', 'HRAS', 'MEF2D']",0.9935611087965842,0,0,5
292,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.7260781815545906,0.8760110064204119,0.2804090048410415,"['LAMB3', 'LAMC3', 'BAD', 'RPS6', 'VEGFB', 'EPOR', 'HSP90B1', 'CREB3', 'GNG10', 'GNG3', 'RAB14', 'CDC37', 'KRAS', 'IKBKG', 'PELO', 'HRAS', 'EIF4B']",0.9935611087965842,0,0,17
293,Common Pathways Underlying Drug Addiction WP2636,0.7443902293893078,0.7683140553803014,0.22679853364462355,"['CALM2', 'ACTG1']",0.9935611087965842,0,0,2
294,Integrated Cancer Pathway WP1971,0.7443902293893078,0.7683140553803014,0.22679853364462355,"['BAD', 'BAX']",0.9935611087965842,0,0,2
295,RANKL/RANK signaling pathway WP2018,0.7443902293893078,0.7683140553803014,0.22679853364462355,"['IKBKG', 'ICAM1']",0.9935611087965842,0,0,2
296,Type 2 papillary renal cell carcinoma WP4241,0.7443902293893078,0.7683140553803014,0.22679853364462355,"['ELOB', 'ELOC']",0.9935611087965842,0,0,2
297,Urea cycle and associated pathways WP4595,0.7443902293893078,0.7683140553803014,0.22679853364462355,"['GOT1', 'PYCR1']",0.9935611087965842,0,0,2
298,Endoderm differentiation WP2853,0.7611527629604414,0.7679480428295594,0.20958930254010089,"['SESN1', 'TCEAL2', 'NABP2', 'NME1']",0.9935611087965842,0,0,4
299,Glioblastoma signaling pathways WP2261,0.7698845731527393,0.7406133724207915,0.19368126936468763,"['KRAS', 'FOXO4', 'HRAS']",0.9935611087965842,0,0,3
300,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.7698845731527393,0.7406133724207915,0.19368126936468763,"['NDUFA13', 'COPS6', 'IKBKG']",0.9935611087965842,0,0,3
301,Calcium Regulation in the Cardiac Cell WP536,0.7816226801668563,0.8028792912513842,0.19781593772883635,"['RGS4', 'YWHAE', 'GNG3', 'YWHAQ', 'PRKAR1A', 'YWHAB', 'ANXA6', 'CALM3', 'CALM2', 'YWHAH']",0.9935611087965842,0,0,10
302,15q13.3 copy number variation syndrome WP4942,0.7822507165231299,0.6915681639085894,0.16983529617694637,['TRPM1'],0.9935611087965842,0,0,1
303,Cytokines and Inflammatory Response WP530,0.7822507165231299,0.6915681639085894,0.16983529617694637,['HLA-DRB1'],0.9935611087965842,0,0,1
304,Disruption of postsynaptic signaling by CNV WP4875,0.7822507165231299,0.6915681639085894,0.16983529617694637,['HOMER1'],0.9935611087965842,0,0,1
305,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,0.7822507165231299,0.6915681639085894,0.16983529617694637,['PTGES'],0.9935611087965842,0,0,1
306,Eicosanoid Synthesis WP167,0.7822507165231299,0.6915681639085894,0.16983529617694637,['PTGES'],0.9935611087965842,0,0,1
307,Energy Metabolism WP1541,0.7822507165231299,0.6915681639085894,0.16983529617694637,['MEF2D'],0.9935611087965842,0,0,1
308,ERK Pathway in Huntington's Disease WP3853,0.7822507165231299,0.6915681639085894,0.16983529617694637,['HRAS'],0.9935611087965842,0,0,1
309,Estrogen signaling pathway WP712,0.7822507165231299,0.6915681639085894,0.16983529617694637,['IKBKG'],0.9935611087965842,0,0,1
310,Fatty Acid Biosynthesis WP357,0.7822507165231299,0.6915681639085894,0.16983529617694637,['ACLY'],0.9935611087965842,0,0,1
311,Hedgehog Signaling Pathway Netpath WP47,0.7822507165231299,0.6915681639085894,0.16983529617694637,['SAP18'],0.9935611087965842,0,0,1
312,IL-7 signaling pathway WP205,0.7822507165231299,0.6915681639085894,0.16983529617694637,['BAD'],0.9935611087965842,0,0,1
313,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.7822507165231299,0.6915681639085894,0.16983529617694637,['SUPT4H1'],0.9935611087965842,0,0,1
314,Intraflagellar transport proteins binding to dynein WP4532,0.7822507165231299,0.6915681639085894,0.16983529617694637,['DYNLL1'],0.9935611087965842,0,0,1
315,MAPK pathway in congenital thyroid cancer WP4928,0.7822507165231299,0.6915681639085894,0.16983529617694637,['KRAS'],0.9935611087965842,0,0,1
316,miR-509-3p alteration of YAP1/ECM axis WP3967,0.7822507165231299,0.6915681639085894,0.16983529617694637,['SPARC'],0.9935611087965842,0,0,1
317,Osteoclast Signaling WP12,0.7822507165231299,0.6915681639085894,0.16983529617694637,['ATP6V1G1'],0.9935611087965842,0,0,1
318,Overview of nanoparticle effects WP3287,0.7822507165231299,0.6915681639085894,0.16983529617694637,['BAX'],0.9935611087965842,0,0,1
319,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.7822507165231299,0.6915681639085894,0.16983529617694637,['ICAM1'],0.9935611087965842,0,0,1
320,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.7822507165231299,0.6915681639085894,0.16983529617694637,['LDHA'],0.9935611087965842,0,0,1
321,Platelet-mediated interactions with vascular and circulating cells WP4462,0.7822507165231299,0.6915681639085894,0.16983529617694637,['ICAM1'],0.9935611087965842,0,0,1
322,Resistin as a regulator of inflammation WP4481,0.7822507165231299,0.6915681639085894,0.16983529617694637,['IKBKG'],0.9935611087965842,0,0,1
323,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.7822507165231299,0.6915681639085894,0.16983529617694637,['CDC37'],0.9935611087965842,0,0,1
324,Bladder cancer WP2828,0.7880743334020497,0.6913249211356467,0.16464792168224524,"['KRAS', 'HRAS']",0.9935611087965842,0,0,2
325,Joubert Syndrome WP4656,0.7880743334020497,0.6913249211356467,0.16464792168224524,"['PDE6G', 'ARL2']",0.9935611087965842,0,0,2
326,Oxidation by Cytochrome P450 WP43,0.7880743334020497,0.6913249211356467,0.16464792168224524,"['CYP26B1', 'CYP51A1']",0.9935611087965842,0,0,2
327,Oxysterols derived from cholesterol WP4545,0.7880743334020497,0.6913249211356467,0.16464792168224524,"['THEM5', 'ACOT4']",0.9935611087965842,0,0,2
328,Endochondral Ossification with Skeletal Dysplasias WP4808,0.7924547638835406,0.7273634322773759,0.1691991762453881,"['HMGCS1', 'ADAMTS1', 'SLC38A2', 'CALM2']",0.9935611087965842,0,0,4
329,Endochondral Ossification WP474,0.7924547638835406,0.7273634322773759,0.1691991762453881,"['HMGCS1', 'ADAMTS1', 'SLC38A2', 'CALM2']",0.9935611087965842,0,0,4
330,Male infertility WP4673,0.7924547638835406,0.7273634322773759,0.1691991762453881,"['PIWIL1', 'CYP26B1', 'DND1', 'HMGA1']",0.9935611087965842,0,0,4
331,T-cell receptor (TCR) signaling pathway WP69,0.7924547638835406,0.7273634322773759,0.1691991762453881,"['MAP4K1', 'IL15RA', 'IKBKG', 'HRAS']",0.9935611087965842,0,0,4
332,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.803914123692217,0.6910812943962116,0.15083735688839567,"['IKBKG', 'CALM2', 'MAPK4']",0.9968818957246405,0,0,3
333,Neural Crest Differentiation WP2064,0.803914123692217,0.6910812943962116,0.15083735688839567,"['PRTG', 'NOTCH4', 'DLL3']",0.9968818957246405,0,0,3
334,Prader-Willi and Angelman Syndrome WP3998,0.803914123692217,0.6910812943962116,0.15083735688839567,"['POMC', 'FEZ1', 'GNRH1']",0.9968818957246405,0,0,3
335,IL-4 signaling pathway WP395,0.8250365482284923,0.628333811299111,0.12084592936788283,"['SOCS3', 'BAD']",0.9968818957246405,0,0,2
336,Fatty acid beta-oxidation WP143,0.8311352672788569,0.5761754662463883,0.10657098193230054,['TPI1'],0.9968818957246405,0,0,1
337,Gastric Cancer Network 1 WP2361,0.8311352672788569,0.5761754662463883,0.10657098193230054,['H3F3A'],0.9968818957246405,0,0,1
338,miRNA regulation of p53 pathway in prostate cancer WP3982,0.8311352672788569,0.5761754662463883,0.10657098193230054,['BAX'],0.9968818957246405,0,0,1
339,Neovascularisation processes WP4331,0.8311352672788569,0.5761754662463883,0.10657098193230054,['NOTCH4'],0.9968818957246405,0,0,1
340,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.8311352672788569,0.5761754662463883,0.10657098193230054,['OMG'],0.9968818957246405,0,0,1
341,One-carbon metabolism WP241,0.8311352672788569,0.5761754662463883,0.10657098193230054,['AHCY'],0.9968818957246405,0,0,1
342,Pathogenesis of SARS-CoV-2 Mediated by nsp9-nsp10 Complex WP4884,0.8311352672788569,0.5761754662463883,0.10657098193230054,['HLA-DRB1'],0.9968818957246405,0,0,1
343,Phosphoinositides metabolism WP4971,0.8311352672788569,0.5761754662463883,0.10657098193230054,['PIP4P1'],0.9968818957246405,0,0,1
344,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.8311352672788569,0.5761754662463883,0.10657098193230054,['GSTP1'],0.9968818957246405,0,0,1
345,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.8311352672788569,0.5761754662463883,0.10657098193230054,['BAX'],0.9968818957246405,0,0,1
346,Transcriptional cascade regulating adipogenesis WP4211,0.8311352672788569,0.5761754662463883,0.10657098193230054,['DDIT3'],0.9968818957246405,0,0,1
347,Hippo-Merlin Signaling Dysregulation WP4541,0.8336048206501441,0.647740726124704,0.1178861078825843,"['PRKAR1A', 'KRAS', 'HRAS']",0.996962537665158,0,0,3
348,Mesodermal commitment pathway WP2857,0.8451140314833244,0.6577898141879185,0.11069531179778117,"['PRKAR1A', 'SESN1', 'NABP2', 'RPL38']",0.9989636076794112,0,0,4
349,PI3K-Akt signaling pathway WP4172,0.8512385672114053,0.7766920502280028,0.12509623688866242,"['LAMB3', 'LAMC3', 'BAD', 'RPS6', 'VEGFB', 'EPOR', 'HSP90B1', 'CREB3', 'GNG10', 'GNG3', 'CDC37', 'COL9A3', 'KRAS', 'IKBKG', 'HRAS', 'EIF4B']",0.9989636076794112,0,0,16
350,DNA IR-double strand breaks and cellular response via ATM WP3959,0.8560924265209602,0.5758412197686645,0.08947244306119585,"['NABP2', 'BAX']",0.9989636076794112,0,0,2
351,Metapathway biotransformation Phase I and II WP702,0.8626841640419514,0.6901029295328582,0.10193277762077016,"['CHST8', 'CYP26B1', 'GPX4', 'GSTO1', 'GSTP1', 'CYP51A1', 'SULT4A1']",0.9989636076794112,0,0,7
352,Proximal tubule transport WP4917,0.8669167629602738,0.6277466609220164,0.08964995238781595,"['ATP6V1G1', 'ATP6V1E1', 'ATP6V1D', 'ATP6V1F']",0.9989636076794112,0,0,4
353,Cancer immunotherapy by PD-1 blockade WP4585,0.8690518846479698,0.4937521107733874,0.06929931811626969,['HLA-DRB1'],0.9989636076794112,0,0,1
354,Genes related to primary cilium development (based on CRISPR) WP4536,0.8690518846479698,0.4937521107733874,0.06929931811626969,['DYNLL1'],0.9989636076794112,0,0,1
355,Heart Development WP1591,0.8690518846479698,0.4937521107733874,0.06929931811626969,['VEGFB'],0.9989636076794112,0,0,1
356,IL1 and megakaryocytes in obesity WP2865,0.8690518846479698,0.4937521107733874,0.06929931811626969,['ICAM1'],0.9989636076794112,0,0,1
357,Striated Muscle Contraction Pathway WP383,0.8690518846479698,0.4937521107733874,0.06929931811626969,['ACTG1'],0.9989636076794112,0,0,1
358,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.8690518846479698,0.4937521107733874,0.06929931811626969,['CALM2'],0.9989636076794112,0,0,1
359,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.8690518846479698,0.4937521107733874,0.06929931811626969,['PPIB'],0.9989636076794112,0,0,1
360,Apoptosis Modulation and Signaling WP1772,0.8756917568898388,0.6391450739276826,0.08484083657643608,"['ENDOG', 'DIABLO', 'BAD', 'CYCS', 'BAX']",0.9989636076794112,0,0,5
361,Tryptophan metabolism WP465,0.8820300354313639,0.5314244115505945,0.06670926518176457,"['DHCR24', 'HSD17B10']",0.9989636076794112,0,0,2
362,MAPK Signaling Pathway WP382,0.8917624862729855,0.7020415967993411,0.08042269304295942,"['MAP4K1', 'HSPA8', 'DUSP3', 'RRAS', 'GADD45A', 'DDIT3', 'STMN1', 'RAC3', 'KRAS', 'IKBKG', 'HRAS']",0.9989636076794112,0,0,11
363,Fluoropyrimidine Activity WP1601,0.8984598691825234,0.4319345941686367,0.04624863559908413,['TDG'],0.9989636076794112,0,0,1
364,Melatonin metabolism and effects WP3298,0.8984598691825234,0.4319345941686367,0.04624863559908413,['CALM2'],0.9989636076794112,0,0,1
365,Complement system WP2806,0.8992040605277632,0.6271576524741082,0.06663254298858116,"['FKBP2', 'FCGR3A', 'RPS19', 'CD59', 'TXN', 'ICAM1']",0.9989636076794112,0,0,6
366,Corticotropin-releasing hormone signaling pathway WP2355,0.9167264858075606,0.5177190213101815,0.04501366112341603,"['POMC', 'STAR', 'CRH']",0.9989636076794112,0,0,3
367,Blood Clotting Cascade WP272,0.9212674191368513,0.38385430347605287,0.031477944328410536,['F8A1'],0.9989636076794112,0,0,1
368,Cardiac Progenitor Differentiation WP2406,0.9212674191368513,0.38385430347605287,0.031477944328410536,['MESP1'],0.9989636076794112,0,0,1
369,Pathways affected in adenoid cystic carcinoma WP3651,0.9212674191368513,0.38385430347605287,0.031477944328410536,['HRAS'],0.9989636076794112,0,0,1
370,Pregnane X receptor pathway WP2876,0.9212674191368513,0.38385430347605287,0.031477944328410536,['PSMC5'],0.9989636076794112,0,0,1
371,Prion disease pathway WP3995,0.9212674191368513,0.38385430347605287,0.031477944328410536,['HSP90B1'],0.9989636076794112,0,0,1
372,Target Of Rapamycin (TOR) Signaling WP1471,0.9212674191368513,0.38385430347605287,0.031477944328410536,['IDI1'],0.9989636076794112,0,0,1
373,3q29 copy number variation syndrome WP4906,0.9214074392373544,0.46035751840168243,0.037681622165764185,"['NCBP2', 'DYNLL1']",0.9989636076794112,0,0,2
374,Toll-like Receptor Signaling Pathway WP75,0.9214074392373544,0.46035751840168243,0.037681622165764185,"['IRF3', 'IKBKG']",0.9989636076794112,0,0,2
375,Peptide GPCRs WP24,0.9304913869603793,0.49295298229789153,0.035513545163546975,"['FSHR', 'OPRL1', 'HCRTR1']",0.9989636076794112,0,0,3
376,Glycogen Synthesis and Degradation WP500,0.9360940397641467,0.4314865930599369,0.02849508883979268,"['CALM3', 'CALM2']",0.9989636076794112,0,0,2
377,ATM Signaling Network in Development and Disease  WP3878,0.9389550507829022,0.3453900709219858,0.021755315863921064,['IKBKG'],0.9989636076794112,0,0,1
378,Nuclear receptors WP170,0.9389550507829022,0.3453900709219858,0.021755315863921064,['NR2F6'],0.9989636076794112,0,0,1
379,Ovarian infertility WP34,0.9389550507829022,0.3453900709219858,0.021755315863921064,['FSHR'],0.9989636076794112,0,0,1
380,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.9389550507829022,0.3453900709219858,0.021755315863921064,['BAX'],0.9989636076794112,0,0,1
381,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.9389550507829022,0.3453900709219858,0.021755315863921064,['RPS6'],0.9989636076794112,0,0,1
382,Vitamin D-sensitive calcium signaling in depression WP4698,0.9389550507829022,0.3453900709219858,0.021755315863921064,['GPX4'],0.9989636076794112,0,0,1
383,Zinc homeostasis WP3529,0.9389550507829022,0.3453900709219858,0.021755315863921064,['MT3'],0.9989636076794112,0,0,1
384,Ectoderm Differentiation WP2858,0.9421337022173223,0.4704384013776279,0.028041929894599672,"['ARHGDIG', 'CELSR2', 'LY6E']",0.9989636076794112,0,0,3
385,Osteoblast differentiation WP4787,0.9421337022173223,0.4704384013776279,0.028041929894599672,"['NOTCH4', 'MAPK4', 'DLL3']",0.9989636076794112,0,0,3
386,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.9481515326276451,0.40601224717016143,0.021616475703439733,"['MYO1E', 'YWHAQ']",0.9989636076794112,0,0,2
387,IL-1 signaling pathway WP195,0.9526713953834067,0.31391933519593096,0.015220456037083087,['IKBKG'],0.9989636076794112,0,0,1
388,Microglia Pathogen Phagocytosis Pathway WP3937,0.9526713953834067,0.31391933519593096,0.015220456037083087,['RAC3'],0.9989636076794112,0,0,1
389,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.9526713953834067,0.31391933519593096,0.015220456037083087,['IRF3'],0.9989636076794112,0,0,1
390,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.9526713953834067,0.31391933519593096,0.015220456037083087,['HRAS'],0.9989636076794112,0,0,1
391,TGF-beta Receptor Signaling WP560,0.9526713953834067,0.31391933519593096,0.015220456037083087,['HRAS'],0.9989636076794112,0,0,1
392,Allograft Rejection WP2328,0.966072763251495,0.36310808567159225,0.01253308346695753,"['HLA-B', 'HLA-DRB1']",0.9989636076794112,0,0,2
393,Netrin-UNC5B signaling pathway WP4747,0.9715547914996895,0.26550281869430803,0.00766177756244378,['ICAM1'],0.9989636076794112,0,0,1
394,ESC Pluripotency Pathways WP3931,0.9726282651657692,0.3448738170347003,0.00957139339869595,"['HRAS', 'MAPK4']",0.9989636076794112,0,0,2
395,Regulation of toll-like receptor signaling pathway WP1449,0.9728407765458953,0.3976989860967762,0.01095058271044945,"['CUEDC2', 'IRF3', 'IKBKG']",0.9989636076794112,0,0,3
396,NRF2 pathway WP2884,0.9732982726307414,0.491749547920434,0.013309051189819746,"['FTH1', 'PRDX1', 'GSTP1', 'TXN', 'SLC5A3', 'FTL']",0.9989636076794112,0,0,6
397,Spinal Cord Injury WP2431,0.9737034550485892,0.46533490011750883,0.01240046900430198,"['BCAN', 'GADD45A', 'APEX1', 'OMG', 'ICAM1']",0.9989636076794112,0,0,5
398,Nephrotic syndrome WP4758,0.9779493430161219,0.24648204435438478,0.0054959104108394845,['MYO1E'],0.9989636076794112,0,0,1
399,Vitamin A and carotenoid metabolism WP716,0.9779493430161219,0.24648204435438478,0.0054959104108394845,['CYP26B1'],0.9989636076794112,0,0,1
400,Monoamine GPCRs WP58,0.9867508080180148,0.21557328605200946,0.0028752616413738425,['HTR5A'],0.9989636076794112,0,0,1
401,Pathways Regulating Hippo Signaling WP4540,0.9867508080180148,0.21557328605200946,0.0028752616413738425,['PRKAR1A'],0.9989636076794112,0,0,1
402,Phosphodiesterases in neuronal function WP4222,0.9867508080180148,0.21557328605200946,0.0028752616413738425,['PDE6G'],0.9989636076794112,0,0,1
403,Vitamin D Receptor Pathway WP2877,0.9899274624538562,0.4296875,0.00434998815046096,"['CDKN2D', 'COLEC11', 'GADD45A', 'DND1', 'S100A6', 'HLA-DRB1']",0.9989636076794112,0,0,6
404,Ciliopathies WP4803,0.9917424209171496,0.3226864640883978,0.0026756715479542077,"['NEK2', 'CCNQ', 'CCDC28B']",0.9989636076794112,0,0,3
405,AMP-activated protein kinase (AMPK) signaling WP1403,0.9920404388516544,0.19153314070571753,0.0015306193879955608,['CCNB1'],0.9989636076794112,0,0,1
406,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.9920404388516544,0.19153314070571753,0.0015306193879955608,['ACTG1'],0.9989636076794112,0,0,1
407,Wnt signaling pathway and pluripotency WP399,0.9938309563899284,0.18141097424412095,0.0011225984621538421,['PPM1J'],0.9989636076794112,0,0,1
408,"GPCRs, Class A Rhodopsin-like WP455",0.9941717903889413,0.46082829311018264,0.002693661145004601,"['MAS1', 'OPN4', 'FSHR', 'GPR22', 'APLNR', 'OPRL1', 'NMUR2', 'HTR5A', 'HCRTR1']",0.9989636076794112,0,0,9
409,Nuclear Receptors Meta-Pathway WP2882,0.9942572064300494,0.5014928845631859,0.0028882714469234106,"['PSMC5', 'GADD45B', 'FTH1', 'CDC37', 'PRDX1', 'GSTP1', 'AIP', 'BAX', 'DBI', 'TXN', 'SLC5A3', 'FTL']",0.9989636076794112,0,0,12
410,Glucocorticoid Receptor Pathway WP2880,0.9962944981251592,0.16405868888138392,0.0006090488933273459,['GADD45B'],0.9989636076794112,0,0,1
411,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.9962944981251592,0.16405868888138392,0.0006090488933273459,['SFRP2'],0.9989636076794112,0,0,1
412,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.9971281888463179,0.15656565656565657,0.00045027385946182436,['SFRP2'],0.9989636076794112,0,0,1
413,"GPCRs, Other WP117",0.9976284199745479,0.22193955428920323,0.0005269725398697712,"['FSHR', 'CELSR2']",0.9989636076794112,0,0,2
414,Complement and Coagulation Cascades WP558,0.9982749829107256,0.1434528500131337,0.00024767229872092923,['CLTC'],0.9989636076794112,0,0,1
415,Wnt signaling WP428,0.9989636076794112,0.13235739831484514,0.00013724532347734049,['SFRP2'],0.9989636076794112,0,0,1
